Crescent Biopharma, Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

11.70

+0.52 (4.65%)

At close: Mar 16, 2026, 4:00 PM EDT

11.58

-0.12 (-1.03%)

After-hours: Mar 16, 2026, 4:10 PM EDT

Crescent Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	213.19	34.77	41.79	47.87	90.25
Cash & Short-Term Investments	213.19	34.77	41.79	47.87	90.25
Cash Growth	513.22%	-16.81%	-12.70%	-46.96%	-34.14%
Accounts Receivable	18	-	-	-	-
Other Current Assets	5.57	0.04	2	2.84	0.53
Total Current Assets	236.66	34.8	43.79	50.71	90.79
Net Property, Plant & Equipment	2.32	-	0.77	0.75	1.95
Other Long-Term Assets	1.22	0.81	0.76	0.34	1.61
Total Assets	240.29	35.62	45.32	51.81	94.35
Accounts Payable	10.14	7.33	0.87	0.97	2.11
Accrued Expenses	16.34	2.23	5.23	6.99	8.72
Current Portion of Leases	0.44	-	0.74	0.92	1
Unearned Revenue	4.16	-	-	-	-
Other Current Liabilities	5	0.06	-	-	-
Total Current Liabilities	36.07	9.61	6.84	8.88	11.82
Long-Term Debt	-	37.48	-	-	-
Long-Term Leases	1.21	-	-	-	-
Total Long-Term Liabilities	1.21	37.48	-	-	-
Total Liabilities	37.28	47.1	6.9	8.88	12.74
Preferred Stock	4	-	-	-	-
Common Stock	0.03	0	-	-	-
Total Common Shareholders' Equity	4.03	0	-	-	-
Minority Interest	-	4	-	-	-
Shareholders' Equity	198.98	-15.48	38.41	42.88	81.55
Total Liabilities & Equity	240.29	35.62	45.32	51.81	94.35
Total Debt	1.64	37.48	0.74	0.92	1
Net Cash (Debt)	211.55	-2.72	41.05	46.95	89.25
Net Cash Growth	-	-	-12.57%	-47.39%	-34.44%
Net Cash Per Share	20.31	-4.21	64.81	89.38	173.47
Book Value	4.03	0	0	0	0
Book Value Per Share	0.39	0.00	-	-	-
Tangible Book Value	4.03	0	0	0	0
Tangible Book Value Per Share	0.39	0.00	-	-	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q